The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel

Brian A. Parsons, Sanchia Goonewardene, Saeed Dabestani, Luis Pacheco-Figueiredo, Yuhong Yuan, Valentin Zumstein, Angela M. Cottrell, Jan Borovicka, Paulo Dinis-Oliveira, Bary Berghmans, Sohier Elneil, John Hughes, Bert E.J. Messelink, Amanda C. de C Williams, Andrew P. Baranowski, Daniel S. Engeler

Forskningsoutput: TidskriftsbidragÖversiktsartikelPeer review

5 Citeringar (SciVal)

Sammanfattning

Chronic pelvic pain (CPP) is chronic or persistent pain perceived in structures related to the pelvis of men and women. Patients with CPP may have pain refractory to conventional management strategies. Botulinum toxin A (BTX-A) injection is a potential therapeutic option in patients with CPP. Beneficial effects of BTX-A on pain, quality of life, and functional symptoms were seen in patients with certain CPP subtypes, but the current evidence level is too weak to allow recommendations about the use of BTX-A for treating CPP. Therefore, larger-scale, multicentre, well-designed, and appropriately powered randomised controlled trials or prospective case-control studies with longer follow-up periods are needed.

Originalspråkengelska
Sidor (från-till)320-338
TidskriftEuropean Urology Focus
Volym8
Utgåva1
Tidigt onlinedatum2021 jan. 29
DOI
StatusPublished - 2022

Ämnesklassifikation (UKÄ)

  • Urologi och njurmedicin

Fingeravtryck

Utforska forskningsämnen för ”The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain Panel”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här